EU action plans and strategies

This action plan presents the concrete actions needed to achieve the priorities of the EU Drugs Strategy, adopted in December 2020. The action plan sets out a specific timetable for these actions...

This document presents the annex to the European Commission's Communication on the EU Agenda and Action Plan on Drugs 2021-25.

This document presents the European Commission's Communication on the EU Agenda and Action Plan on Drugs 2021-25.

This document presents the Council of the European Union's Drugs Strategy 2021-25.

There are currently no authorised vaccines for COVID-19 in the European Union (EU). The European Medicines Agency (EMA) is liaising closely with developers of potential COVID-19 vaccines, mobilising its own resources and...

A general resource giving information on the process and benefits of vaccination, recent developments in finding a vaccine for approval and use in EU Member States, and trusted sources for further information.

The development and distribution of an effective and safe vaccine against the coronavirus represents a lasting solution to the pandemic and a cornerstone of the European Commission's coronavirus response.

On 7 December 2012, the Justice and Home Affairs Council of the European Union endorsed a new EU drugs strategy (2013–20) ). In line with the Strategy stipulation that its detailed implementation...

At its meeting of December 1999 in Helsinki the European Council endorsed the European Union Drugs Strategy (2000-2004) . The strategy covers all EU drug related activities unitl the end of 2004...

CELAD ( European Committee to Combat Drugs) Report to the European Council meeting in Rome on 13 and 14 December 1990. Background: The call for a common approach to the drugs phenomenon...